Skip to main content
. 2015 Jul 16;4:358. doi: 10.1186/s40064-015-1123-3

Figure 1.

Figure 1

A diagram of the study design. Enrollment of a patient needs more than 4 weeks after the last chemotherapy. Ad-NK4 is injected into the pleural cavity and then the patient will be monitored. The clinical study ends after day 29 but we will follow-up the patient thereafter.